Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Appl Thromb Hemost ; 16(3): 306-12, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19221099

ABSTRACT

Our aim was to investigate the CD40-CD40 ligand system in preeclamptic women. We also studied CD62P and platelet-monocyte aggregates, which have been closely linked to the CD40-CD40L system. Platelet expression of CD40L and CD62P and expression of CD40 on monocytes and platelet-monocyte aggregates were determined by flow cytometry in whole blood from 23 preeclamptic women, 23 normotensive pregnant women, and 23 nonpregnant women. The preeclamptic women showed a significant increase in CD40L and CD62P on platelets and in CD40 on monocytes when compared with normotensive pregnant women and nonpregnant women (all P < .001). There was a significant increase in platelet-monocyte aggregates in preeclamptic women (P < .001) and normotensive pregnant women (P = .003) compared with nonpregnant women. Preeclampsia is associated with activation of the CD40-CD40L system. The activation of this system may contribute to the development or maintenance of the proinflammatory and prothrombotic milieu found in preeclampsia.


Subject(s)
Blood Platelets/chemistry , CD40 Antigens/blood , CD40 Ligand/blood , Flow Cytometry , Monocytes/chemistry , Pre-Eclampsia/blood , Pregnancy/blood , Adult , Case-Control Studies , Cell Aggregation , Female , HELLP Syndrome/blood , Humans , Inflammation/etiology , P-Selectin/blood , Platelet Activation , Pre-Eclampsia/physiopathology , Pregnancy Complications/etiology , Thrombophilia/etiology , Young Adult
2.
Int J Gynaecol Obstet ; 105(3): 257-60, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19272596

ABSTRACT

OBJECTIVE: To investigate the CD40-CD40 ligand (CD40L) system in women with pre-eclampsia. METHODS: Expression of CD40 on monocytes and expression of CD40 and CD40L on platelets were determined by whole blood flow cytometry in 23 women with pre-eclampsia and in 23 normotensive pregnant women. Serum levels of soluble CD40L in both groups of women were measured by enzyme-linked immunosorbent assay. RESULTS: There was a significantly higher expression of CD40 and CD40L on platelets and CD40 on monocytes in the women with pre-eclampsia compared with normotensive pregnant women (P<0.001 for all comparisons). The serum concentration of soluble CD40L was significantly higher in women with pre-eclampsia compared with normotensive pregnant women (P=0.012). CONCLUSION: Pre-eclampsia is associated with activation of the CD40-CD40L system. The activation of this system may contribute to the development or maintenance of the proinflammatory and prothrombotic responses, increased cytokine production, and endothelial cell dysfunction found in pre-eclampsia.


Subject(s)
CD40 Antigens/genetics , CD40 Ligand/biosynthesis , Pre-Eclampsia/metabolism , Up-Regulation , Adult , Blood Platelets/metabolism , CD40 Ligand/genetics , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry/methods , Humans , Monocytes/metabolism , Pre-Eclampsia/genetics , Pre-Eclampsia/physiopathology , Pregnancy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...